A citation-based method for searching scientific literature

B Wang, J Zhong, H Lin, Z Zhao, Z Yan, H He, Y Ni, D Liu, Z Zhu. Diabetes Obes Metab 2013
Times Cited: 129



Thomas Blevins, John Pullman, Jaret Malloy, Ping Yan, Kristin Taylor, Christine Schulteis, Michael Trautmann, Lisa Porter. J Clin Endocrinol Metab 2011
Times Cited: 301




List of shared articles



Times cited


Predictors of Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Patients with Type 2 Diabetes and Obesity.
Alina Yu Babenko, Daria A Savitskaya, Yulia A Kononova, Aleksandra Yu Trofimova, Anna V Simanenkova, Elena Yu Vasilyeva, Evgeny V Shlyakhto. J Diabetes Res 2019
8

Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force.
Sanjay Kalra, Ashok Kumar Das, Rakesh Kumar Sahay, Manash Pratim Baruah, Mangesh Tiwaskar, Sambit Das, Sudip Chatterjee, Banshi Saboo, Ganapathi Bantwal, Saptarshi Bhattacharya,[...]. Diabetes Ther 2019
9

GLP-1 Receptor Agonists and Cardiovascular Disease: a Meta-Analysis of Recent Cardiac Outcome Trials.
Xiaoming Jia, Mahboob Alam, Yumei Ye, Mandeep Bajaj, Yochai Birnbaum. Cardiovasc Drugs Ther 2018
18

Cardiovascular Effects of Different GLP-1 Receptor Agonists in Patients with Type 2 Diabetes.
Gül Bahtiyar, Jean Pujals-Kury, Alan Sacerdote. Curr Diab Rep 2018
15


Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists.
Yu Mi Kang, Chang Hee Jung. Endocrinol Metab (Seoul) 2016
25


Glucagon-like peptide-1 receptor agonists favorably address all components of metabolic syndrome.
Sanjay Chatterjee, Samit Ghosal, Saurav Chatterjee. World J Diabetes 2016
11

Cardiometabolic Effects of a New Class of Antidiabetic Agents.
Cyrus V Desouza, Namita Gupta, Anery Patel. Clin Ther 2015
28

Incretin-based therapies for obesity treatment.
Aline Haas de Mello, Morgana Prá, Larissa Colonetti Cardoso, Rosiane de Bona Schraiber, Gislaine Tezza Rezin. Metabolism 2015
19